Warp Drive Bio Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Warp Drive Bio Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11145
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Warp Drive Bio Inc (Warp Drive) is an inventor of therapeutic agents that exploits molecules and createstransformative medicines through nature. The company utilizes its proprietary genomic mining and small molecule assisted receptor targeting platform to develop novel medicines. Its SMART platform provides solutions to the pharmaceutical opportunities. The company develops natural products in various therapeutic areas such as infectious diseases and cancer. It is deploying genome mining technologies to access powerful natural product drugs that have been historically concealed within microbe. Warp Drive is headquartered in Cambridge, Massachusetts, the US.

Warp Drive Bio Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Warp Drive Bio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Warp Drive Bio Raises US$75 Million In Series A Venture Financing 10
Partnerships 12
Warp Drive Bio Enters into Partnership with Roche 12
Warp Drive Bio Enters to Agreement with GlaxoSmithKline 13
Licensing Agreements 14
Sanofi Enters into Licensing Agreement with Warp Drive Bio 14
Acquisition 15
Revolution Medicines to Acquire Warp Drive Bio 15
Warp Drive Bio Inc – Key Competitors 16
Warp Drive Bio Inc – Key Employees 17
Warp Drive Bio Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Key Facts 2
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Warp Drive Bio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Warp Drive Bio Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Warp Drive Bio Raises US$75 Million In Series A Venture Financing 10
Warp Drive Bio Enters into Partnership with Roche 12
Warp Drive Bio Enters to Agreement with GlaxoSmithKline 13
Sanofi Enters into Licensing Agreement with Warp Drive Bio 14
Revolution Medicines to Acquire Warp Drive Bio 15
Warp Drive Bio Inc, Key Competitors 16
Warp Drive Bio Inc, Key Employees 17

List of Figures
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Warp Drive Bio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Warp Drive Bio Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exelon Corporation:企業の戦略・SWOT・財務情報
    Exelon Corporation - Strategy, SWOT and Corporate Finance Report Summary Exelon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Orion New Zealand Ltd:企業の戦略的SWOT分析
    Orion New Zealand Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Prinzhorn Holding GmbH:企業の戦略・SWOT・財務情報
    Prinzhorn Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Prinzhorn Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Jordan Trade Facilities Company PLC (JOTF):企業の財務・戦略的SWOT分析
    Jordan Trade Facilities Company PLC (JOTF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • EyeGate Pharmaceuticals Inc (EYEG):企業の財務・戦略的SWOT分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontop …
  • Ramsay Health Care Ltd (RHC):企業の財務・戦略的SWOT分析
    Ramsay Health Care Ltd (RHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Post Holdings Inc:企業の戦略・SWOT・財務分析
    Post Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Post Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Meritz Fire & Marine Insurance Co., Ltd.:企業の戦略・SWOT・財務分析
    Meritz Fire & Marine Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meritz Fire & Marine Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • NTT Communications Corporation:戦略・SWOT・企業財務分析
    NTT Communications Corporation - Strategy, SWOT and Corporate Finance Report Summary NTT Communications Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Seegene Inc (096530):企業の財務・戦略的SWOT分析
    Summary Seegene Inc (Seegene) is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions u …
  • RealPage, Inc.:企業のM&A・事業提携・投資動向
    RealPage, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RealPage, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Open Text Corporation:企業の戦略・SWOT・財務分析
    Open Text Corporation - Strategy, SWOT and Corporate Finance Report Summary Open Text Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Diversicare Healthcare Services Inc (DVCR):製薬・医療:M&Aディール及び事業提携情報
    Summary Diversicare Healthcare Services Inc (Diversicare), formerly Advocat Inc is a healthcare service provider that offers post acute care services and short term rehabilitation and long-term care services to nursing home patients. The company’s services include life steps rehabilitation program, …
  • Medicago Inc:企業のM&A・事業提携・投資動向
    Medicago Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medicago Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Mitsui Chemicals, Inc.:企業の戦略・SWOT・財務分析
    Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Magnotta Winery Corporation:企業の戦略・SWOT・財務分析
    Magnotta Winery Corporation - Strategy, SWOT and Corporate Finance Report Summary Magnotta Winery Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • ConocoPhillips (COP)-エネルギー分野:企業M&A・提携分析
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • Aselsan Elektronik Sanayi Ve Ticaret A.S.:企業の戦略・SWOT・財務分析
    Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Cooper Tire & Rubber Company:企業の戦略・SWOT・財務情報
    Cooper Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report Summary Cooper Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Nippon Chemiphar Co Ltd (4539):企業の財務・戦略的SWOT分析
    Summary Nippon Chemiphar Co Ltd (Nippon Chemiphar) is a provider of pharmaceutical drugs and health-related services. The company manufactures, supplies, imports and exports ethical pharmaceuticals and diagnostic agents. It offers diagnostic products, such as IgE NC, a diagnostic kit that provides r …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆